Answers are grounded in this paper and cite their sources.
Analyzes active site variations in Cu/ZrO2 catalysts, revealing implications for catalyst design in CO2 hydrogenation.
The well-known structure sensitivity of CO 2 hydrogenation to methanol has shown to be an impactful topic for the performance of the catalyst and yet remains unaddressed for Cu nanoparticles supported on ZrO 2 , a material that has shown to be involved in the active site and the reaction mechanism of methanol formation.Herein, Cu/ZrO 2 catalysts were studied to unravel the underlying structure-activity relationships by combining surface and bulk characterization techniques, kinetic measurements, operando-DRIFTS and DFT calculations.Contrary to Cu over inert supports, the results showed different trends and two distinct kinetic regimes.For Cu nanoparticles larger than 2 nm, they are in accordance with previously reported results, this is, a change in the number of active sites, without affecting the nature of them.Conversely, it is demonstrated that the active sites are markedly different over the regime of nanoparticles smaller than 2 nm, accessed for ultralow Cu contents of 0.1 wt %, as evidenced from the systematic change of kinetic parameters and from operando-DRIFTS.The distinct active sites were identified as isolated Cu species (i.e., single atoms and Cu incorporated into the lattice of ZrO 2 ) and highly stable Cu clusters, both of which would allocate the formation of products for low metal contents.The results are certainly related to the interaction between Cu and ZrO 2 and unequivocally disclose the relationship between activity regimes and the nature of active sites as a function of the Cu particle size.Furthermore, they demonstrate that distinct active sites can be accessed just by varying the metal content on active reducible supports.As such, the findings a re o f p articular r elevance f or t he f undamental u nderstanding o f t he i nteraction b etween C u a nd Z rO 2 a nd its interdependence with the size of the Cu nanoparticles, as well as for the rational design of catalysts for CO 2 hydrogenation to methanol.
No takes yet. Share an insight, caveat, or question.
Vergara et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: